Company intelligence / Profile preview

OCS Life Sciences

Ownership: Private
Employees: ~33
Development stage: Other

Overview

Provides statistical programming, biostatistics, data management, CDISC standardization/training, and regulatory submission support to pharma/biotech clients across all phases of clinical trials. No proprietary clinical results as it does not own drug assets.

Therapeutic areas: Other
Industry: Contract Research Organization

Partnerships

SAS Institute (Gold Partner)CDISC Gold Member organization

Beyond the preview

Go deeper on OCS Life Sciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on OCS Life Sciences.

Explore the full profile